Form 4 holding
Chief Executive Officer, Director
Maze Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 186,901
- Estimated value
- $5,803,799
- Report date
- 02 Nov 2026
- Price
- $31.05
- Ownership
- Coloma Family Trust